http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-19517421-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0efa077d881a96aeb1e29b21ef1bbb58
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C213-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-24
filingDate 1995-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d4678e9b476fc80261b9413dc43655b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1bf379e3832fe828abecad34df79da0
publicationDate 1996-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-19517421-A1
titleOfInvention Synthesis of optically active aminoindanol
abstract A process for preparing enantiomer-pure cis1-amino-2-hydroxyindane is characterised in that: (a) racemic trans1-aminoindan-2-ol is reacted according to known processes with acids or acid derivatives having the general formula RCOX, yielding type (A) amides, in which the substituents have the following meanings: R stands for hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl and phenyl, groups that may carry one to three halogen atoms and/or one to three among the following residues: cyano, C1-C6 alkoxy, C1-C6 alkylthio phenyl, phenylthio and phenoxy, the phenyl residues in turn carrying one to three among the following groups: C1-C4 alkyl, C1-C4 alkoxy, halogen, cyano and nitro; X stands for OH, halogen, OR<1> and SR<1>, in which R<1> stands for alkyl C1-C6, phenyl and COR. In a second step (b), a supersaturated solution or melt of racemic amide (A) is blended with seed crystals of an enantiomer, then (c) the precipitated crystals are isolated and the remaining mother liquor or melt is again supersaturated, after separation of racemic amide (A), and blended with seed crystals of the other enantiomer in order to selectively crystallise said enantiomer. Finally (d), the thus obtained enantiomer-pure transamide is reacted according to known methods to yield enantiomer-pure cis1-amino-2-hydroxyindane.
priorityDate 1995-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2725045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429223770
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415791935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429223771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420128500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23443464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426164693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420128540
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426123450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457834974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409432810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407981510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425061474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419489467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420352779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20070078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414199489
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393790
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153751282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420332851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153751283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10888732
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448908428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448930606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9866743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451621547
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457586405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6931154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421254616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19357388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9916275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22101329
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429223769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153751281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394858

Total number of triples: 74.